• Global medical anti-embolism stocking market size was valued at USD 2.42 billion in 2024. The market is projected to grow from USD 2.62 billion in 2025 to USD 3.72 billion by 2032, exhibiting a CAGR of 6.9% during the forecast period.
Email: help@intelmarketresearch.com +91 9169164321
• Medical anti-embolism stockings, clinically known as compression stockings, are specialized therapeutic garments designed to prevent venous thromboembolism (VTE) by applying graduated pressure to the lower extremities. These medical devices exert maximum compression at the ankle (typically 15-20 mmHg or higher) with progressively decreasing pressure up the leg, enhancing venous blood flow and reducing stasis. They are classified as Class I medical devices in most regulatory frameworks and are extensively used in both clinical and homecare settings.
Email: help@intelmarketresearch.com +91 9169164321
By Application
• Ambulatory Patients
• Post-operative Patients
• Pregnant Women
• Doctor-prescribed Use
• Other
•Jobst (Essity) (Germany)
•Medtronic plc (Ireland)
•BSN Medical GmbH (Germany)
•3M Company (U.S.)
•FarrowMed (Australia)
•Juzo (Germany)
•Therafirm (U.S.)
Email: help@intelmarketresearch.com +91 9169164321
